Hepatitis A Virus Cellular Receptor 2
"Hepatitis A Virus Cellular Receptor 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An Ig domain-containing membrane receptor that is expressed by TH1 CELLS. It regulates the activation of MACROPHAGES and inhibits TH1-mediated auto- and alloimmune responses to promote IMMUNE TOLERANCE.
| Descriptor ID |
D000072597
|
| MeSH Number(s) |
D12.776.395.550.479 D12.776.543.550.437 D12.776.543.750.830.219
|
| Concept/Terms |
Hepatitis A Virus Cellular Receptor 2- Hepatitis A Virus Cellular Receptor 2
- CD366 Antigen
- Antigen, CD366
- T-Cell Immunoglobulin and Mucin Domain-Containing Protein 3
- T Cell Immunoglobulin and Mucin Domain Containing Protein 3
- TIMD3 Protein
- HAVCR2 Protein
- T-Cell Immunoglobulin Mucin Receptor 3
- T Cell Immunoglobulin Mucin Receptor 3
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis A Virus Cellular Receptor 2".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis A Virus Cellular Receptor 2".
This graph shows the total number of publications written about "Hepatitis A Virus Cellular Receptor 2" by people in this website by year, and whether "Hepatitis A Virus Cellular Receptor 2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 0 | 2 | 2 |
| 2020 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 2 | 2 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hepatitis A Virus Cellular Receptor 2" by people in Profiles.
-
Immune checkpoint TIM-3 regulates microglia and Alzheimer's disease. Nature. 2025 May; 641(8063):718-731.
-
Non-viral TRAC-knocked-in CD19KICAR-T and gp350KICAR-T cells tested against Burkitt lymphomas with type 1 or 2 EBV infection: In vivo cellular dynamics and potency. Front Immunol. 2023; 14:1086433.
-
mTOR regulates T cell exhaustion and PD-1-targeted immunotherapy response during chronic viral infection. J Clin Invest. 2023 01 17; 133(2).
-
Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma. Cancer Immunol Res. 2022 03 01; 10(3):303-313.
-
PD-1+ stemlike CD8 T cells are resident in lymphoid tissues during persistent LCMV infection. Proc Natl Acad Sci U S A. 2020 02 25; 117(8):4292-4299.
-
Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1+ Stem-like CD8+ T Cells during Chronic Infection. Immunity. 2019 12 17; 51(6):1043-1058.e4.
-
Impaired enolase 1 glycolytic activity restrains effector functions of tumor-infiltrating CD8+ T cells. Sci Immunol. 2019 01 25; 4(31).
-
Longitudinal assessment of T cell inhibitory receptors in liver transplant recipients and their association with posttransplant infections. Am J Transplant. 2018 02; 18(2):351-363.
-
PD-1 and Tim-3 regulate the expansion of tumor antigen-specific CD8? T cells induced by melanoma vaccines. Cancer Res. 2014 Feb 15; 74(4):1045-55.
-
T-cell immunoglobulin mucin-3 is underexpressed on myeloblasts in untreated myelodysplastic syndrome. Leuk Lymphoma. 2014 Mar; 55(3):689-91.